Investors

Investment Case

Why invest in ChemoTech?

Unique, patented and certified TSE technology that enables more effective and gentler cancer treatments
Demonstrated clinical results with great potential beyond superficial tumours. Treatments in pancreatic cancer patients have provided unique initial responses and indicate ground-breaking opportunities ahead
ChemoTech is in the commercialization phase, which has the potential to generate strong cash flows in the short term
The company has ready-made products for both human and veterinary medicine, where veterinary medicine requires a shorter evaluation period and thus opportunities for orders in the near term
ChemoTech’s product in human medicine, IQwave™, has the potential to become a standard treatment in India. The company’s product in veterinary medicine, vetIQure™, is evaluated by Europe’s largest veterinary chains and a number of high-profile veterinary chains in the US
Centres of Excellence established in the UK (RVC) and in the US (FloridaWild) for veterinary medicine, ensuring growth potential as the technology gains widespread recognition
Distribution agreements for human and animal care in place for the Australian market – a highly strategic market due to the high prevalence of cancer cases and significant investments made by the country in the cancer treatment field

Get in touch

Are you interested in our products?

Our team is here to help with any questions about our products, patents or anything else you may need help with.